Reduction of Activin A gives rise to comparable expression of key definitive endoderm and mature beta cell markers
#CHIR99021 ; #2520691 ; *** BioGems 제품이나 Peprotech 으로 표기 Regen Med. 2024 Jan;19(1):47-63. Aldyn Wildey 1, Stephen Harrington 1, Lisa Stehno-Bittel 1 2, Francis Karanu 1 Affiliations expand Abstract Aim: Cell therapies for diabetes rely on differentiation of stem cells into insulin-producing cells, which is complex and expensive. Our goal was to evaluate production costs and test ways to reduce it. Methods: Cost of Goods (COGs) …